Ortho Elmiron

Site Map

ELMIRON^® is the only oral interstitial cystitis medication FDA approved to treat the bladder pain and discomfort of IC.

When you have interstitial cystitis (IC), it's easy to feel like you're the only one. But, believe it or not, interstitial cystitis affects millions of women and men in the US alone.

Every patient diagnosed with IC has a different story to tell. Here are just four who were willing to speak candidly about their IC condition and their treatment with ELMIRON^®. These stories are from individual patients and are not necessarily representative of results that can be expected by all patients taking ELMIRON^®.

Meet Terry-Jo Myers

A severe onset of IC at 21 almost took away Terry's dream of being on the LPGA Tour. Terry noticied improvement in symptons after taking ELMIRON^® for about 3–6 months.

Individual results may vary.

Read Terry-Jo Myers' ELMIRON^® video transcript

Other Patient Stories

Hope Lovings
ELMIRON success story: Hope Lovings

Hear Hope's story Kristina Lee
ELMIRON success story: Kristina Lee

Hear Kristina's story Randy Campbell
ELMIRON success story: Randy Campbell

Hear Randy's story

NEXT: Living with IC

ELMIRON^® is indicated for the relief of bladder pain or discomfort associated with interstitial cystitis.
ELMIRON^® is available by prescription only.

IMPORTANT SAFETY INFORMATION

ELMIRON^® is a weak anticoagulant (blood thinner) which may increase bleeding. Call your doctor if you will be undergoing surgery or will begin taking anticoagulant therapy such as warfarin, heparin, high doses of aspirin, or anti-inflammatory drugs such as ibuprofen.

ELMIRON^® should not be taken if you have a known hypersensitivity to the drug or similar drugs.

The most common side effects observed in clinical trials were blood in stool, diarrhea, nausea, hair loss, headache, rash, upset stomach, abdominal pain, liver function abnormalities, and dizziness. Hair loss, when it occurred, was almost always limited to a single area of the scalp, and grew back when ELMIRON^® was discontinued.

The mechanism of action of ELMIRON^® in interstitial cystitis is not fully understood.

Please see full Product Information for ELMIRON^®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2009. All rights reserved. Your use of the information on this site is subject to the terms of our Legal Notice. This site is published by Ortho Women's Health & Urology™, Division of Ortho-McNeil-Janssen

ELMIRON^® is a registered trademark of IVAX Research, Inc, under license to Ortho-McNeil-Janssen Pharmaceuticals, Inc.

This information is intended for use by our customers, patients and healthcare professionals in the United States only. Ortho Women's Health & Urology™ recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The Full Product Information included here may not be appropriate for use outside the United States.
Last modified November 12, 2009

ELMIRON® is the only oral interstitial cystitis medication FDA approved to treat the bladder pain and discomfort of IC.

ELMIRON^® is the only oral interstitial cystitis medication FDA approved to treat the bladder pain and discomfort of IC.